Know2eat

Vitamin D3 (cholecalciferol)

Vitamins

What vitamin d3 (cholecalciferol) may help with

Ranked by how strong the human evidence is — best supported first.

Best supportedBone mineral densityStrong evidence· 4 sources

Then, in order

About Vitamin D3 (cholecalciferol)

The form of vitamin D that human skin makes from 7-dehydrocholesterol under ultraviolet B light. Supplements are usually derived from lanolin in sheep wool, with a lichen-derived vegan version now widely available.

Vitamin D has the strangest evidence profile of any nutrient: overwhelming for what deficiency does, and repeatedly disappointing for what supplementation adds once you are replete. Rickets and osteomalacia are unambiguous deficiency diseases with an unambiguous remedy. Beyond that, the observational literature linking low vitamin D to almost every disease studied has largely failed to translate — VITAL, with 25,871 participants on 2,000 IU/day, found no reduction in cancer or cardiovascular events, and large trials have failed to show benefit for fractures or falls in replete community-dwelling adults. The most useful reading is that low blood vitamin D is often a marker of ill health and inactivity rather than a cause of it, and that supplementation helps the people who are genuinely short of it.

Sold as
Softgel, Tablet, Oil drops, Spray, Lichen-derived vegan capsule, High-dose prescription capsule
Also known as
Cholecalciferol, Vitamin D, Sunshine vitamin

Regulation: The IOM set an RDA of 600 IU/day for adults 19–70 and 800 IU/day above 70, with a Tolerable Upper Intake Level of 4,000 IU (100 µg)/day; EFSA set the same upper limit. Prescription-strength 50,000 IU capsules exist for correcting documented deficiency under supervision. Retail products at 10,000 IU per capsule are sold freely and exceed the upper limit in a single dose.

What the research used

The amounts, forms and durations published trials of Vitamin D3 (cholecalciferol) actually administered.

These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.

  • Studied for Recommended Dietary Allowance, adults

    600–800 IU

    Strong

    600 IU/day to age 70 and 800 IU/day above it, set to cover bone health at minimal sun exposure. The UK, Nordic and other national bodies set values in the same range; disagreement is about the target blood level, not the arithmetic.

  • Studied for Tolerable Upper Intake Level, adults

    4000 IU

    Strong

    Set by both the IOM and EFSA at 4,000 IU (100 µg)/day. Sustained intakes well above this — usually 10,000 IU/day or more for months — are where hypercalcaemia has been reported.

  • Studied for Correcting documented deficiency

    50000 IU

    Moderate

    Weekly capsule · 6–8 weeks, then reassessment

    A prescribing convention used with blood monitoring, not a self-administered regimen. Repletion protocols vary between countries and specialties.

  • Studied for Large prevention trials

    2000 IU

    Strong

    Daily capsule · 5 years

    The VITAL dose. It found no reduction in the primary cancer or cardiovascular endpoints, which is the single most important result to know before buying vitamin D for anything other than bone health.

This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.

When it was taken

Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.

Each timing below was actually compared against an alternative in a trial, which is unusual.

  • With food

    Moderate

    Taken with the largest fat-containing meal of the day, absorption improves substantially — a controlled study found roughly 50% higher blood 25-hydroxyvitamin D on that schedule compared with taking it away from a substantial meal. One of the few timing recommendations in this catalogue that has actually been tested.

    Timing was tested. A trial compared this window against another and reported a difference.

  • Any time

    Moderate

    Daily, weekly and monthly dosing all raise blood levels; very large intermittent boluses do not, and have been associated with more falls and fractures in older adults. Frequency appears to matter more than time of day.

    Timing was tested. A trial compared this window against another and reported a difference.

The evidence in depth

Best supported: Strong

What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.

Bone mineral density

Bone Health
Strong evidence

In people who are genuinely deficient, vitamin D corrects rickets and osteomalacia, and combined calcium and vitamin D has reduced hip fracture rates in institutionalised older adults with low intakes — a result reproduced across trials and meta-analyses. In replete, community-dwelling adults with adequate calcium, supplementation has not reduced fractures, and several large trials report no effect on bone density at all. Both halves of that sentence are well established.

What may be going on: Calcitriol, the active hormone, drives intestinal calcium absorption. Without it, calcium uptake falls to a fraction of normal and bone mineralisation fails regardless of calcium intake.

Strong evidence. Consistent findings across multiple good-quality human studies.

View the 4 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Immune function

Immune Health
Limited evidence

A meta-analysis using individual participant data reported a small reduction in acute respiratory infections, concentrated in people with the lowest starting levels and in those given daily or weekly rather than bolus doses. Subsequent large trials have been null, and the effect, if real, is modest.

What may be going on: Vitamin D receptors are expressed on immune cells and calcitriol induces antimicrobial peptides such as cathelicidin in laboratory work.

Limited evidence. Early human work, or mostly lab and animal research.

View the 3 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Cardiovascular risk markers

Heart Health
Not enough evidence

Large randomised trials, including VITAL and D-Health, found no reduction in cardiovascular events or all-cause mortality from supplementation in generally replete populations. This is one of the clearest null results in modern nutrition research and it contradicts a very large observational literature.

Not enough evidence. Not enough human research to say anything useful yet.

View the 2 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Mood

Mental Wellbeing
Not enough evidence

Evidence is limited for vitamin D and depressive symptoms. Low blood levels track with depression in observational data, but the large VITAL-DEP trial of 2,000 IU/day found no reduction in depression risk or mood scores over five years.

Not enough evidence. Not enough human research to say anything useful yet.

View the 1 source

Deep research mode adds each paper’s own conclusion and stated limitations.

Things to know

Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.

  • Too much

    Hypercalcaemia at sustained very high doses

    Vitamin D toxicity is real but requires sustained excess — typically 10,000 IU/day or more for months, or dosing errors in compounded products. It presents as hypercalcaemia: nausea, thirst, frequent urination, confusion, kidney stones and, if prolonged, calcification of soft tissue and kidney damage. Because vitamin D is fat-soluble and stored, it resolves slowly after stopping.

  • Too much

    High intermittent bolus dosing increased falls and fractures

    A single annual 500,000 IU dose increased falls and fractures in older women in one randomised trial, and monthly high-dose regimens have produced similar signals. Whatever the mechanism, the pattern argues against the "one big dose occasionally" approach that some clinics and products use.

  • Worth knowing

    Conditions where vitamin D can be actively dangerous

    Sarcoidosis, tuberculosis and some lymphomas cause unregulated conversion of vitamin D to its active form, so supplementation can precipitate hypercalcaemia at ordinary doses. Primary hyperparathyroidism, advanced kidney disease and a history of calcium kidney stones all warrant medical supervision rather than self-dosing.

  • Interaction

    Interactions with thiazides, digoxin and enzyme-inducing drugs

    Interacts withThiazide diuretics, digoxin, phenytoin, carbamazepine, rifampicin, orlistat

    Thiazide diuretics reduce calcium excretion and can compound hypercalcaemia. Raised calcium increases the risk of digoxin toxicity. Phenytoin, carbamazepine, rifampicin and glucocorticoids accelerate vitamin D breakdown, while orlistat and bile-acid sequestrants reduce its absorption.

  • Worth knowing

    Label accuracy has been a documented problem

    Independent analyses of retail vitamin D products have found actual content ranging from a small fraction to well above the labelled amount, with compounding errors behind several published cases of toxicity. Third-party verification is worth looking for, particularly on high-strength products.

In the food catalogue

The whole-food form, where one exists. The evidence for a concentrated extract rarely transfers to the food, or the other way round — these are cross-links, not equivalents.

SardinesA modest oily-fish source, bones included.UV-exposed mushroomsProduce vitamin D2 rather than D3 when exposed to ultraviolet light.Wild Atlantic salmonOne of the few foods with meaningful naturally occurring vitamin D3.

Evidence ratings on this page: 1 strong evidence, 1 limited evidence, 2 not enough evidence.

Supplements are sold in the US without pre-market review of efficacy or safety. Nothing on this page is a recommendation to take Vitamin D3 (cholecalciferol), or a dose to follow.